Mainz Biomed (MYNZ) Competitors $2.04 +0.05 (+2.51%) Closing price 04:00 PM EasternExtended Trading$2.06 +0.02 (+1.23%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MYNZ vs. FBLG, TPST, ALXO, QTTB, CVKD, TENX, CARA, BCAB, SLGL, and LSTAShould you be buying Mainz Biomed stock or one of its competitors? The main competitors of Mainz Biomed include FibroBiologics (FBLG), Tempest Therapeutics (TPST), ALX Oncology (ALXO), Q32 Bio (QTTB), Cadrenal Therapeutics (CVKD), Tenax Therapeutics (TENX), Cara Therapeutics (CARA), BioAtla (BCAB), Sol-Gel Technologies (SLGL), and Lisata Therapeutics (LSTA). These companies are all part of the "pharmaceutical products" industry. Mainz Biomed vs. Its Competitors FibroBiologics Tempest Therapeutics ALX Oncology Q32 Bio Cadrenal Therapeutics Tenax Therapeutics Cara Therapeutics BioAtla Sol-Gel Technologies Lisata Therapeutics Mainz Biomed (NASDAQ:MYNZ) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Which has stronger earnings & valuation, MYNZ or FBLG? FibroBiologics has lower revenue, but higher earnings than Mainz Biomed. FibroBiologics is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMainz Biomed$890K7.88-$21.65M-$65.60-0.03FibroBiologicsN/AN/A-$11.16M-$0.21-3.22 Is MYNZ or FBLG more profitable? Mainz Biomed's return on equity of 0.00% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets Mainz BiomedN/A N/A N/A FibroBiologics N/A -1,022.04%-117.56% Do analysts recommend MYNZ or FBLG? Mainz Biomed currently has a consensus target price of $14.00, indicating a potential upside of 586.27%. FibroBiologics has a consensus target price of $13.00, indicating a potential upside of 1,821.09%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts plainly believe FibroBiologics is more favorable than Mainz Biomed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Which has more volatility and risk, MYNZ or FBLG? Mainz Biomed has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.78, meaning that its share price is 178% less volatile than the S&P 500. Does the media favor MYNZ or FBLG? In the previous week, Mainz Biomed had 1 more articles in the media than FibroBiologics. MarketBeat recorded 2 mentions for Mainz Biomed and 1 mentions for FibroBiologics. FibroBiologics' average media sentiment score of 1.89 beat Mainz Biomed's score of 1.21 indicating that FibroBiologics is being referred to more favorably in the news media. Company Overall Sentiment Mainz Biomed Positive FibroBiologics Very Positive SummaryFibroBiologics beats Mainz Biomed on 7 of the 13 factors compared between the two stocks. Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MYNZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYNZ vs. The Competition Export to ExcelMetricMainz BiomedMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.02M$3.04B$5.74B$9.51BDividend YieldN/A2.40%4.60%3.99%P/E Ratio-0.0321.1828.1120.03Price / Sales7.88337.65460.63103.88Price / CashN/A43.2336.5559.01Price / Book0.788.368.655.90Net Income-$21.65M-$55.19M$3.25B$258.66M7 Day Performance7.94%5.89%4.20%2.23%1 Month Performance41.67%17.63%10.83%12.77%1 Year Performance-85.59%5.10%34.67%19.36% Mainz Biomed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYNZMainz Biomed2.7388 of 5 stars$2.04+2.5%$14.00+586.3%-86.2%$7.02M$890K-0.0330Positive NewsFBLGFibroBiologics3.8153 of 5 stars$0.64+1.7%$13.00+1,931.3%-86.2%$25.40MN/A-3.0510Positive NewsGap UpTPSTTempest Therapeutics2.3401 of 5 stars$6.90-0.7%$30.00+334.8%-71.7%$25.39MN/A-0.3820Positive NewsALXOALX Oncology3.8453 of 5 stars$0.47-2.8%$3.30+603.9%-91.3%$25.03MN/A-0.1940QTTBQ32 Bio2.5162 of 5 stars$2.03-23.7%$12.17+499.3%-93.6%$24.77M$1.16M-0.4139High Trading VolumeCVKDCadrenal Therapeutics3.1064 of 5 stars$12.50-3.3%$32.00+156.0%N/A$24.59MN/A-1.354Positive NewsTENXTenax Therapeutics1.8291 of 5 stars$5.90+1.7%$17.50+196.6%+77.6%$24.47MN/A-2.389Positive NewsCARACara Therapeutics0.2154 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeBCABBioAtla1.8783 of 5 stars$0.40+4.0%$5.00+1,153.1%-78.0%$23.31M$11M-0.3360SLGLSol-Gel Technologies3.2974 of 5 stars$8.30+1.9%$40.00+382.1%+65.8%$23.15M$11.54M-1.7750Positive NewsGap DownLSTALisata Therapeutics2.9953 of 5 stars$2.63-3.0%$15.00+470.3%-20.6%$22.66M$1M-1.1430Positive NewsGap Down Related Companies and Tools Related Companies FibroBiologics Alternatives Tempest Therapeutics Alternatives ALX Oncology Alternatives Q32 Bio Alternatives Cadrenal Therapeutics Alternatives Tenax Therapeutics Alternatives Cara Therapeutics Alternatives BioAtla Alternatives Sol-Gel Technologies Alternatives Lisata Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MYNZ) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed NV Please log in to your account or sign up in order to add this asset to your watchlist. Share Mainz Biomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MYNZ Stock Alerts